|
2-(1,5-dimethyl-3-phenyl-1H-pyrrol-2-yl)-N-{4-[4-(5-fluoro-pyrimidin-2-yl)piperazin-1-yl]-phenyl}-2-oxo-acetamide |
|---|---|
| Trade Name | |
| Orphan Indication | Scedosporiosis |
| EU Market Approval | EU |
| EU Designation Date | 2016-08-29 00:00:00 |
| Sponsor | F2G Ltd |
|
2-(1,5-dimethyl-3-phenyl-1H-pyrrol-2-yl)-N-{4-[4-(5-fluoro-pyrimidin-2-yl)piperazin-1-yl]-phenyl}-2-oxo-acetamide |
|---|---|
| Trade Name | |
| Orphan Indication | Scedosporiosis |
| EU Market Approval | EU |
| EU Designation Date | 2016-08-29 00:00:00 |
| Sponsor | F2G Ltd |